Teachers Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Teachers Advisors’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.48M	Buy	318,477 +72,811	+30%	+$329K	﹤0.01%	2123
2018 Q4	$1.03M	Buy	245,666 +4,011	+2%	+$20.4K	﹤0.01%	2168
2018 Q3	$1.51M	Buy	241,655 +15,696	+7%	+$121K	﹤0.01%	2117
2018 Q2	$1.82M	Buy	225,959 +7,116	+3%	+$54.3K	﹤0.01%	2002
2018 Q1	$1.63M	Buy	218,843 +375	+0.2%	+$2.49K	﹤0.01%	1944
2017 Q4	$1.3M	Buy	218,468 +11,614	+6%	+$70.6K	﹤0.01%	2099
2017 Q3	$1.52M	Buy	206,854 +1,353	+0.7%	+$8.59K	﹤0.01%	2002
2017 Q2	$1.4M	Buy	205,501 +85,022	+71%	+$628K	﹤0.01%	2034
2017 Q1	$1.14M	Buy	120,479 +8,544	+8%	+$85.3K	﹤0.01%	2110
2016 Q4	$967K	Buy	111,935 +2,769	+3%	+$20.5K	﹤0.01%	2193
2016 Q3	$691K	Hold	109,166	–	–	﹤0.01%	2290
2016 Q2	$461K	Buy	109,166 +7,442	+7%	+$35.9K	﹤0.01%	2461
2016 Q1	$444K	Hold	101,724	–	–	﹤0.01%	2406
2015 Q4	$624K	Hold	101,724	–	–	﹤0.01%	2276
2015 Q3	$582K	Hold	101,724	–	–	﹤0.01%	2295
2015 Q2	$759K	Hold	101,724	–	–	﹤0.01%	2281
2015 Q1	$608K	Hold	101,724	–	–	﹤0.01%	2323
2014 Q4	$769K	Hold	101,724	–	–	﹤0.01%	2179
2014 Q3	$528K	Hold	101,724	–	–	﹤0.01%	2372
2014 Q2	$438K	Sell	101,724 -8,214	-7%	-$31.4K	﹤0.01%	2510
2014 Q1	$450K	Buy	109,938 +31,830	+41%	+$163K	﹤0.01%	2460
2013 Q4	$416K	Buy	78,108 +3,280	+4%	+$14.4K	﹤0.01%	2487
2013 Q3	$376K	Buy	74,828 +10,846	+17%	+$58.8K	﹤0.01%	2496
2013 Q2	$285K	Buy	+63,982	New	+$287K	﹤0.01%	2569

Other funds holding PGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Teachers Advisors's PGNX Position: Q1 2019 in Review

Teachers Advisors increased its Progenics Pharmaceuticals Inc (PGNX) stake by 30% in Q1 2019, buying an estimated $329K and bringing the position to 318,477 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2123.

Teachers Advisors first reported a position in PGNX in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.82M in Q2 2018. 148 funds tracked by Wall St. Rank hold PGNX as of Q1 2019.

Teachers Advisors held 318,477 shares of Progenics Pharmaceuticals Inc worth $1.48M as of Q1 2019.
Teachers Advisors bought 72,811 Progenics Pharmaceuticals Inc shares in Q1 2019, an estimated $329K.
Progenics Pharmaceuticals Inc made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2123 holding.
Teachers Advisors first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and has held it in 24 quarters since.
Teachers Advisors's Progenics Pharmaceuticals Inc position peaked at $1.82M in Q2 2018.
148 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.